GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (LSE:RENX) » Definitions » Interest Expense

Renalytix (LSE:RENX) Interest Expense : £0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Renalytix Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Renalytix's interest expense for the three months ended in Mar. 2024 was £ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was £0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Renalytix's Operating Income for the three months ended in Mar. 2024 was £ -4.83 Mil. Renalytix's Interest Expense for the three months ended in Mar. 2024 was £ 0.00 Mil. GuruFocus does not calculate Renalytix's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Renalytix Interest Expense Historical Data

The historical data trend for Renalytix's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renalytix Interest Expense Chart

Renalytix Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Interest Expense
Get a 7-Day Free Trial -0.02 - - - -

Renalytix Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Renalytix Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Renalytix  (LSE:RENX) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Renalytix's Interest Expense for the three months ended in Mar. 2024 was £0.00 Mil. Its Operating Income for the three months ended in Mar. 2024 was £-4.83 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was £3.85 Mil.

Renalytix's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

GuruFocus does not calculate Renalytix's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Renalytix (LSE:RENX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (LSE:RENX) » Definitions » Interest Expense
Comparable Companies
LSE:COG LSE:INHC LSE:FDBK LSE:TRLS LSE:IQAI AQSE:DXSP LSE:KOO LSE:INS VEEV GEHC TSE:2413 HQY ASX:PME RCM TXG DOCS PGNY EVH TDOC HKSE:01833
Traded in Other Exchanges
RNLX:USA RTNXF:USA 2O9:Germany
Address
5-7 Cranwood Street, Finsgate, London, GBR, EC1V 9EE
Website
https://www.renalytix.com
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Renalytix (LSE:RENX) Headlines

From GuruFocus

Paul Singer Buys Reed Elesvier

By matsandalex matsandalex • 12-14-2012

Investing in Information

By Vanina Egea Vanina Egea • 03-06-2014

Causeway International's Top Five Holdings

By Monica Wolfe Monica Wolfe • 08-29-2013

Omnicom Health Group acquires Elsevier's Pharma Communications business in Japan, rebrands as EMC K.K.

By PRNewswire PRNewswire • 03-27-2018